Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are strongly suspected of having breast cancer, or who have already been diagnosed with breast cancer (either early-stage or spread to other parts of the body).
• People who have a tumour or lesion that their treating doctor considers safe to biopsy.
• People who are 18 years of age or older.
• People whose general health and ability to carry out daily activities falls within a range considered acceptable for this trial (confirm with trial site).
• People who are able to understand and are willing to sign a consent form agreeing to take part.
• People who are on blood-thinning medication may still be considered, provided that medication can be safely stopped for a period of time before the biopsy, as determined by the study doctor.
• People who need a biopsy of a vital organ (such as lung or liver) must have blood counts showing their immune cells and platelets are at or above certain minimum levels (confirm with trial site for exact values).

Who may not be able to join:

• People who have another illness or condition that their doctor believes would make participation in this trial unsafe or inappropriate.
• People who have dementia, significantly altered mental state, or a psychiatric condition that would prevent them from understanding or agreeing to take part.
• People who have a history of a serious or life-threatening allergic reaction to local anaesthetics such as lidocaine or xylocaine.
• People who are pregnant, due to potential risks associated with sedation used for certain biopsies and possible radiation exposure from CT-guided procedures.
• People whose heart condition makes a biopsy unsafe, in the opinion of their treating doctor.
• People who are currently receiving certain anti-cancer drugs that affect blood vessel growth (such as bevacizumab) may not be eligible for biopsies of vital organs (such as lung or liver) if fewer than six weeks have passed since their last dose of that drug, due to concerns about increased bleeding risk and slower healing.
• People receiving those same anti-cancer drugs who are having a biopsy of the breast, a lymph node near the surface of the body, or a skin biopsy must have had their last dose of that drug at least two weeks before the biopsy.

Important: Always verify eligibility with the trial site directly before applying.